Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Certa Therapeutics logo — Developing innovative precision therapies for the treatment...

Certa Therapeutics

Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases

Founded 2018 10 employees Grant Total: $25.00M Biotechnology, Health and Wellness

General Information

Company Name Certa Therapeutics
Founded Year 2018
Employees 10
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

Get notified when Certa Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Certa Therapeutics

Certa Therapeutics is a biotechnology startup founded in 2018 with a focus on developing innovative precision treatments for inflammatory and fibrotic diseases. The company's slogan, "Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases," reflects its mission. With its last investment of $25.00MGrant received on 04 June 2018, Certa Therapeutics has garnered support from notable investors such as Uniseed, University of Melbourne, and Brandon Capital. This demonstrates not only investor confidence but also affirms the company's potential to make significant advancements in the field of Health and Wellness.

Taxonomy: Precision Therapy, Inflammatory Diseases, Fibrotic Diseases, Drug Development, Therapeutics, Innovation, Medical Research, Precision Treatment, Biopharmaceutical, Life Sciences, Precision Medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 3
Investor Investor Investor
04 Jun 2018

Certa Therapeutics Alternatives & Competitors

Certa Therapeutics vs
ENDPOINT HEALTH
ENDPOINT HEALTH United States

Precision immunology therapies

Series A
7 employees
Health Care
Certa Therapeutics vs
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. United States

Precision medicines for serious immune mediated diseases.

Series B
34 employees
Biotechnology, Health Care
Compare Certa Therapeutics vs Santa Ana Bio, Inc.
Certa Therapeutics vs
Mirador Therapeutics
Mirador Therapeutics

Redefining Immunology and Inflammation with Precision

Series B
95 employees
Biotechnology, Health Care
Compare Certa Therapeutics vs Mirador Therapeutics

FAQ About Certa Therapeutics

Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases
Certa Therapeutics was founded in 2018.
Certa Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Certa Therapeutics has approximately 10 employees.
Certa Therapeutics has completed 1 funding round, raising a total of $25.00M. The latest funding stage is Grant.
Top alternatives and competitors to Certa Therapeutics include ENDPOINT HEALTH, Santa Ana Bio, Inc., Mirador Therapeutics, Avalo Therapeutics, Promedior. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Certa Therapeutics and ENDPOINT HEALTH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Certa Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy